<p>Biofilms and aggregates were grown for 24 h to 72-h prior to tobramycin (100 ug/ml) treatment for 24-h. For visualization by CLSM a GFP-tagged PAO1 strain (green) was used and stained with the DNA stain PI (red) for visualizing dead bacteria. Panels A, B and C represent biofilm tolerance on day 1, 2 and 3 respectively andpanels D and E are aggregates on day 1 and 2. Length of size bars: 20 µm.</p
Biofilm-residing bacteria embedded in an extracellular matrix are protected from diverse physico-c...
Fig 8: Effect of preventive and curative treatments of P. aeruginosa PA14 biofilm in a dynamic model...
Pseudomonas aeruginosa and Escherichia coli are able to form bacteria biofilms in the human body and...
For a chronic infection to be established, bacteria must be able to cope with hostile conditions suc...
<p>(A) PBS treatment; (B) 160 μg/mL nitroxoline; (C) 160 μg/mL colistin; (D) 320 μg/mL nitroxoline; ...
<p>(A) Young <i>P. aeruginosa</i> biofilms pre-grown for 5 h in the absence of antibiotic before bei...
<p>(A) <i>P. aeruginosa</i> PAK biofilm formation upon addition of kanamycin. Top panel shows staini...
For a chronic infection to be established, bacteria must be able to cope with hostile conditions suc...
Objectives: The aim of the study was to determine the susceptibility of active and dormant cell popu...
<p>Dispersal of <i>P. aeruginosa</i> PAO1 WT biofilms grown in continuous-flow cells was assessed by...
<p>Twenty-four-hour biofilms of <i>E. coli</i> TG1 were preformed in M63B1<sub>Gluc</sub> and treate...
Purpose: Cystic fibrosis patients often develop chronic infections with Pseudomonas aeruginosa (PA)....
ObjectivesThe selection and dose of antibiotic therapy for biofilm-related infections are based on t...
The roles of slow antibiotic penetration, oxygen limitation, and low metabolic activity in the toler...
<p>Viable cell densities (mean ± standard error, three replicates) in 48 hours, intact biofilm popul...
Biofilm-residing bacteria embedded in an extracellular matrix are protected from diverse physico-c...
Fig 8: Effect of preventive and curative treatments of P. aeruginosa PA14 biofilm in a dynamic model...
Pseudomonas aeruginosa and Escherichia coli are able to form bacteria biofilms in the human body and...
For a chronic infection to be established, bacteria must be able to cope with hostile conditions suc...
<p>(A) PBS treatment; (B) 160 μg/mL nitroxoline; (C) 160 μg/mL colistin; (D) 320 μg/mL nitroxoline; ...
<p>(A) Young <i>P. aeruginosa</i> biofilms pre-grown for 5 h in the absence of antibiotic before bei...
<p>(A) <i>P. aeruginosa</i> PAK biofilm formation upon addition of kanamycin. Top panel shows staini...
For a chronic infection to be established, bacteria must be able to cope with hostile conditions suc...
Objectives: The aim of the study was to determine the susceptibility of active and dormant cell popu...
<p>Dispersal of <i>P. aeruginosa</i> PAO1 WT biofilms grown in continuous-flow cells was assessed by...
<p>Twenty-four-hour biofilms of <i>E. coli</i> TG1 were preformed in M63B1<sub>Gluc</sub> and treate...
Purpose: Cystic fibrosis patients often develop chronic infections with Pseudomonas aeruginosa (PA)....
ObjectivesThe selection and dose of antibiotic therapy for biofilm-related infections are based on t...
The roles of slow antibiotic penetration, oxygen limitation, and low metabolic activity in the toler...
<p>Viable cell densities (mean ± standard error, three replicates) in 48 hours, intact biofilm popul...
Biofilm-residing bacteria embedded in an extracellular matrix are protected from diverse physico-c...
Fig 8: Effect of preventive and curative treatments of P. aeruginosa PA14 biofilm in a dynamic model...
Pseudomonas aeruginosa and Escherichia coli are able to form bacteria biofilms in the human body and...